MedTrace Logo

MalnutritiOn Assessment With biOelectrical impedaNce Analysis in gastRic Cancer patIentS Undergoing Multimodal trEatment

NCT05723718 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2023-02-13

No results posted yet for this study

Summary

The aim of this single-arm prospective, multicenter, cross-sectional study is to evaluate the nutritional status and body composition on tumor regression grade with bioelectrical impedance analysis in gastric cancer patients undergoing multimodal treatment. Results of this study will reveal whether nutritional status and body composition assessment based on bioelectrical impedance analysis will become a validated and objective tool to support clinical decisions in gastric cancer patients undergoing multimodal treatment.

Conditions

Interventions

OTHER

Observational Survey

Evaluation of the nutritional status and body composition on tumor regression grade in gastric cancer patients scheduled for multimodal treatment. Nutritional status assessment will include: selected clinical variables evaluation (weight, BMI, nutritional status scales), bioelectrical impedance analysis and selected laboratory parameter assessment. After inclusion in the study, each patient will have four consecutive nutritional status assessments: (1) one day prior staging laparoscopy or during qualification to neoadjuvant chemotherapy, (2) one day before the gastrectomy, (3) one month after the gastrectomy, (4) after the last cycle of adjuvant chemotherapy.

Sponsors & Collaborators

  • Erasmus Medical Center

    collaborator OTHER

  • Ohio State University

    collaborator OTHER

  • Poznan University of Medical Sciences

    collaborator OTHER

  • Jagiellonian University

    collaborator OTHER

  • Medical University of Lublin

    lead OTHER

Principal Investigators

  • Zuzanna Pelc, PhD · Medical University of Lublin

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-20
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05723718 on ClinicalTrials.gov